CDK4 and urothelial carcinoma: miR-34a negatively regulates the cell cycle by reducing CCND1 (cyclin D1) and CDK4 (cyclin dependent kinase 4) levels; its downregulation promotes a more aggressive behavior of FGFR3 in urothelial carcinoma cases [197].